Omega Healthcare Investors financials
$46.54−0.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $328.2M | $323.0M | $266.0M | $264.5M | $282.5M | $276.8M | $235.2M | $231.5M | $214.3M | $242.8M | $327.4M | $210.2M |
| Gross profit | $328.2M | $323.0M | $266.0M | $264.5M | $282.5M | $276.8M | $235.2M | $231.5M | $214.3M | $242.8M | $327.4M | $210.2M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $188.6M | $205.6M | $151.4M | $159.6M | $163.5M | $153.8M | $129.5M | $127.5M | $118.8M | $129.7M | $193.3M | $75.8M |
| Net income | $360.5M | $139.7M | $163.8M | $177.9M | $134.5M | $95.8M | $113.3M | $111.8M | $113.9M | $69.4M | $55.0M | $91.4M |
| Net margin | 109.8% | 43.3% | 61.6% | 67.2% | 47.6% | 34.6% | 48.2% | 48.3% | 53.1% | 28.6% | 16.8% | 43.5% |
| Diluted EPS | $1.19 | $0.47 | $0.52 | $0.59 | $0.46 | $0.33 | $0.39 | $0.42 | $0.45 | $0.27 | $0.21 | $0.37 |
| EBITDA | $275.1M | $291.2M | $240.3M | $243.4M | $260.2M | $236.3M | $210.6M | $219.8M | $203.0M | $209.5M | $197.3M | $182.4M |
| Operating cash flow | $217.7M | $215.5M | $230.6M | $226.7M | $239.3M | $182.0M | $229.0M | $184.9M | $184.1M | $151.5M | $165.0M | $171.0M |
| Free cash flow | $94.9M | $77.7M | $146.6M | $136.3M | -$290.2M | $88.3M | $25.0M | $57.6M | $34.7M | $116.8M | $83.6M | $90.2M |
| Diluted shares | 316.3M | 315.1M | 313.5M | 308.2M | 303.2M | 294.9M | 287.4M | 275.6M | 261.5M | 257.3M | 256.6M | 256.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $39.0M | $26.1M | $27.0M | $737.2M | $734.2M | $368.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.02B | $4.44B | $4.26B | $4.99B | $5.00B | $4.45B |
| Total assets | $10.01B | $10.23B | $10.05B | $10.60B | $10.55B | $9.71B |
| Total liabilities | $4.37B | $4.78B | $4.61B | $5.35B | $5.36B | $4.77B |
| Shareholders' equity | $5.64B | $5.46B | $5.44B | $5.24B | $5.19B | $4.93B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology